AbCheck
About:
AbCheck provides an antibody discovery platform that discovers and optimizes human therapeutic antibodies.
Website: https://abcheckantibodies.com/
Description:
AbCheck provides an antibody discovery platform that discovers and optimizes human therapeutic antibodies. The company provides drug candidates through discovery collaborations or strategic research partnerships based on flexible business terms including royalty-free agreements. It generates target-specific human antibody domains which can be used in distinct therapeutic formats. AbCheck was founded in 2009 and is a spin-out of Affimed’s technology discovery platform. It is a wholly owned subsidiary of Affimed GmbH, a biopharmaceutical company developing highly targeted cancer immunotherapies.
1M EUR
$1M to $10M
Plzen, Plzensky kraj, Czech Republic
2009-01-01
info(AT)abcheckantibodies.com
11-50
2023-03-09
Private
© 2025 bioDAO.ai